CAREFUL

Who we are

Clinical coordination is broken. Not because clinicians don't care — because the tools around them were never built to answer the questions that matter most: what's happening now, what's happening next, and who is responsible.

We built CAREFUL to answer them. We are a team of clinicians, technologists and operators who believe that safe, effective care depends on clear communication and named accountability — and that the tools exist to make that the norm, not the exception.

We hold ourselves to the same standard we set for our platform. As a company and as individuals, we aspire to be CAREFUL:
Committed, Active, Responsive, Energetic, Focused, Uniform and Leading.

Our team

Dr DJ Hamblin-Brown

Dr DJ Hamblin-Brown

Founder, CEO & Clinical Safety Officer

DJ qualified as a doctor in the UK in 1996 and is a Fellow of the Royal College of Emergency Medicine (FRCEM). He practised as an emergency physician in the NHS before becoming Vice-president of Medical Affairs at United Family Healthcare in Beijing, where he was senior medical officer accountable for safety and quality of clinical activity across 7 general hospitals and 14 primary-care clinics. He was also Group Medical Director for Aspen Healthcare, overseeing 9 hospitals and clinics across the UK. DJ has dedicated most of his working life to improving healthcare and promotes a balance of compassion and rigour to healthcare leadership.

Roohi Hamlani

Roohi Hamlani

Co-founder & Head of Patient Participation

Roohi is a biochemist, nutritionist, wellness entrepreneur and vet tech graduate with over twenty years of consumer marketing experience at companies like J&J, Hershey and LG. Her proudest professional achievement was creating a continuity of care model for chronic disease management at United Family Healthcare in China, which focused on improving health and wellness knowledge, behaviour, and outcomes in communities and among employees. She firmly believes that improving health requires 'many active participants, working together, with accountability, over time' and always keeps the consumer/patient at the centre of her work.

Tom Kobialka

Tom Kobialka

Chief Technology Officer

Tom completed a BSc Eng with Honours at the Australian National University in Canberra before embarking on a career as a software engineer. Working for academia and businesses of various scales in Australia, Europe and the UK, Tom has spent more than 18 years in the technology sector. Broadly experienced, he applies his varied skills using a vast range of languages. Fluent in Polish, German as well as English, Tom has contributed academic research in the field of computer science. His work has been published in a number of journals and includes a book chapter.

David Wright

David Wright

Co-Investor & Director APAC

David started his career in teaching before earning his MBA specialising in healthcare delivery systems. He has held executive roles as CEO of AGPAL (Australia's national accreditation system for general practice) and CEO of the Royal Australian College of General Practitioners. He has consulted in the UAE and Bahrain on major projects, advised the Royal Medical Services, and consulted for the WHO, European Commission, and major healthcare organisations. David focuses on supporting innovative medical sector startups.

Sarah-Jane Coetzee

Sarah-Jane Coetzee

Head of Marketing & Communication

Sarah-Jane has 20 years of marketing experience, primarily in financial services, specialising in corporate communication. She holds a master's degree in intercultural communication and is experienced in managing change projects. A professional editor and full member of the Professional Editors' Guild, she is skilled in marketing strategy and tactics and known for creative and effective communication solutions.

Dr Shane McKeown

Dr Shane McKeown

Medical Director UK & Data Protection Officer

Shane is a London-based doctor and entrepreneur, founder of Harley Street Digital and Medical MBA. He has developed curricula and delivered teaching for the NHS Foundation programme, international CME services, and the PLAB examination. His expertise lies in leveraging emerging technologies for health and social care, focusing on modernising healthcare through technology.

Our advisors

Philip Beer

Philip Beer

Physician Scientist & Cancer Biologist

Philip is a physician scientist, cancer biologist and oncology drug developer. He started life as a haematologist and has accrued over 16 years frontline healthcare experience including clinical haemato-oncology, pathology and molecular diagnostics. This was followed by academic research in Cambridge, UK and Vancouver, Canada. For the last 11 years, Philip has worked in the oncology biopharma sector, focussed on biomarker discovery and early phase oncology drug development, leading scientific and clinical development of small molecule and antibody programmes.

Jason Sprague

Jason Sprague

Healthcare Transformation Advisor

Jason leads Sprague & Co., a network of experts delivering complex transformations across energy, infrastructure, digital technology and government. He chairs the APM's Contracts and Procurement Interest Network and brings deep expertise in change management, innovation delivery and commercial model design. Jason advises CAREFUL on transformation strategy — helping health systems navigate the organisational and procurement complexity of adopting new coordination tools at scale.

James Truell

James Truell

Co-investor & NHS Doctor

James is a resident doctor working in paediatrics who has a passion for integrating the newest technology into his patient care. After graduating Imperial College in 2019, he worked at Southampton General Hospital before moving to New Zealand for two years. Currently he is working in the paediatric emergency department at Chelsea & Westminster Hospital. He has published peer reviewed research and presented internationally.

Dr David Brown

Dr David Brown

Investor & Pharmaceutical Leader

David has over 50 years of experience in pharmaceutical and biotechnology leadership, having held senior executive roles at Zeneca, Pfizer, GlaxoWellcome and Roche. He is co-inventor on the Viagra patent and led the team that developed it over eight years — alongside Relpax — achieving combined sales of over $50 billion. He served as Director and Global Head of Drug Discovery at Roche, overseeing 2,000+ scientists across five research sites. He is Chairman and co-founder of Healx, a Cambridge University spin-out applying machine learning to rare disease.

Jeff Staples

Jeff Staples

Healthcare Investor

Jeff is a physician and health system executive with nearly 20 years of leadership across acute care hospitals, academic medical centres and ambulatory services in Southeast Asia, the Middle East and China. He has led two transformative transactions exceeding $1 billion, including a London Stock Exchange IPO and a New York Stock Exchange listing. Known for driving clinical quality and shareholder value simultaneously, he brings deep expertise in strategic planning, multi-site system integration and physician engagement to complex, large-scale health organisations.

Prof. Angus Wallace

Prof. Angus Wallace

Emeritus Professor of Orthopaedics

Angus is Emeritus Professor of Orthopaedic and Accident Surgery at the University of Nottingham, where he held the chair for over 30 years. He co-founded the British Elbow and Shoulder Society and has published over 300 research papers. He is widely known for the post-Kegworth research that changed the airline brace position adopted by all UK carriers. He served as Dean of the Faculty of Health Informatics at the Royal College of Surgeons of Edinburgh and leads the UK Digital Health Collaborative.

Our investors

Artesian
Brink
Disruptive Capital
Oxford University Hospitals

Join our mission

We're always looking for talented individuals who share our passion for transforming healthcare.